for the period of Baht 47.8 million as compared to the 2017 , the company and its subsidiaries have profit for the period of Baht 307.4 million, decreased Baht 355.2 million or 116% for the following
earnings or sufficient liquidity to carry out the share repurchase project as disclosed. Such act was deemed a dissemination of false information or details that could materially mislead the public and
Baht 24.46 million, a decrease of 62.93% compared to 2017. Final earnings per share resulted at Baht 1.15. Total Revenues 2018 2017 Change (Million Baht) (Million Baht) (%) Sales 2,020.63 2,147.64 (5.91
Administrative expenses decreased by 6% yoy mostly was attributed to the staff cost. Earnings before interest, taxes and depreciation (“EBITDA”) EBITDA (not included other income) increased substantially by 16
, Section 44 and Section 64 of the Constitution of the Kingdom of Thailand so permit by virtue of law, the Capital Market Supervisory Board hereby issues the following regulations: Clause 1 In this
, Section 44 and Section 64 of the Constitution of the Kingdom of Thailand so permit by virtue of law, the Capital Market Supervisory Board hereby issues the following regulations: Clause 1 In this
, Section 43, Section 44 and Section 64 of the Constitution of the Kingdom of Thailand so permit by virtue of law, the Capital Market Supervisory Board hereby issues the following regulations: Clause 1 In
Ventures 2nd Quarter 2018 MD&A 1 Indorama Ventures Public Company Ltd Management Discussion and Analysis 2nd Quarter 2018 Structural Improvements Driving Earnings Momentum 2Q18 Core EBITDA up 63% YoY, 1H18
promising growth was attributed by the increase of number of patients as well as bill amount per patient. A yoy slight decline of social security revenue were mainly from high care cost revenue following the
21.66 12.88% EBIT 74.01 160.8 -53.97% Net Profit 63.05 130.46 -51.67% Basic Earnings per Share (Baht) 0.32 0.65 -50.77% Thus, the gross profit margin was at 11.70%. After deducted the financial cost and